Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Ginkgo Bioworks Holdings, Inc. | DNA | 36.49K | $361.65K |
Kardigan, Inc. | KARD | 50K | $1.19M |
Quest Diagnostics Incorporated | DGX | 50K | $10.6M |
Disc Medicine, Inc. | IRON | 65K | $4.75M |
Moderna, Inc. | MRNA | 75K | $5.25M |
Alnylam Pharmaceuticals, Inc. | ALNY | 75K | $22.58M |
uniQure N.V. | QURE | 150K | $6.91M |
Recursion Pharmaceuticals, Inc. | RXRX | 165.32K | $606.74K |
Guardant Health, Inc. | GH | 185K | $27.76M |
Monte Rosa Therapeutics, Inc. | GLUE | 186.01K | $4.5M |
Veracyte, Inc. | VCYT | 276.31K | $16.23M |
Intellia Therapeutics, Inc. | NTLA | 355K | $6.01M |
Editas Medicine, Inc. | EDIT | 445K | $1.44M |
Sarepta Therapeutics, Inc. | SRPT | 470K | $8.45M |
GRAIL Inc. | GRAL | 480K | $32.77M |
Illumina, Inc. | ILMN | 530K | $93.19M |
Septerna Inc | SEPN | 553.27K | $18.53M |
Applied Aerospace & Defense, Inc. | AADX | 645.69K | $17.67M |
Scholar Rock Holding Corporation | SRRK | 665K | $36.58M |
Hims & Hers Health, Inc. | HIMS | 700K | $24.27M |